Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Clinical trial NCT06298968 · RECRUITING
Trial details
- NCT number
- NCT06298968
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-26
- Primary completion
- 2025-02-25
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.